Deletion of Hyaluronan Synthase 3 Inhibits Neointimal Hyperplasia in Mice

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 36, Issue 2, 2016, Pages e9-e16

  Kiene, Lena S ^a   Homann, Susanne ^a   Suvorava, Tatsiana ^a   Rabausch, Berit ^a   Müller, Julia ^a   Kojda, Georg ^a   Kretschmer, Inga ^a   Twarock, Sören ^a   Dai, Guang ^a   Deenen, René ^a   Hartwig, Sonja ^b,c   Lehr, Stefan ^b,c   Köhrer, Karl ^a   Savani, Rashmin C ^d   Grandoch, Maria ^a   Fischer, Jens W ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

carotid arteries; extracellular matrix; hyaluronan; neointima; smooth muscle cells

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYALURONAN SYNTHASE 3; INTEGRIN; INTERLEUKIN 13; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BB; SYNTHETASE; TRANSCRIPTOME; UNCLASSIFIED DRUG; BECAPLERMIN; GLUCURONOSYLTRANSFERASE; HAS3 PROTEIN, MOUSE;

ACTIN FILAMENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE; CALCIUM SIGNALING; CAROTID ARTERY; CAROTID ARTERY LIGATION; CELL COUNT; CELL DENSITY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME INHIBITION; EXTRACELLULAR MATRIX; FOCAL ADHESION; GENE DELETION; HYPERPLASIA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOUSE; NEOINTIMA; NEOINTIMAL HYPERPLASIA; NONHUMAN; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN MODIFICATION; RNA ANALYSIS; VASCULAR RING; VASCULAR SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE CELL; VASODILATATION; 129 MOUSE; ANIMAL; C57BL MOUSE; CAROTID ARTERY DISEASE; CELL CULTURE; CELL MOTION; COMMON CAROTID ARTERY; DEFICIENCY; DRUG EFFECTS; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; GENOTYPE; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHENOTYPE; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CELL;

ANIMALS; CAROTID ARTERY DISEASES; CAROTID ARTERY, COMMON; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; EXTRACELLULAR MATRIX; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION; GENOTYPE; GLUCURONOSYLTRANSFERASE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-SIS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 84955567520     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.115.306607     Document Type: Article

References (33)

1. Turley EA, Noble PW, Bourguignon LY, Signaling properties of hyaluronan receptors. J Biol Chem 2002 277 4589 4592. doi: 10.1074/jbc.R100038200.
2. Evanko SP, Angello JC, Wight TN, Formation of hyaluronan-and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1999 19 1004 1013
3. Riessen R, Wight TN, Pastore C, Henley C, Isner JM, Distribution of hyaluronan during extracellular matrix remodeling in human restenotic arteries and balloon-injured rat carotid arteries. Circulation 1996 93 1141 1147
4. Silverman-Gavrila R, Silverman-Gavrila L, Bendeck MP, Cell division fidelity is altered during the vascular response to injury: its novel role in atherosclerosis progression. Am J Pathol 2013 182 628 639. doi: 10.1016/j.ajpath.2012.11.007.
5. Ma X, Pearce JD, Wilson DB, English WP, Edwards MS, Geary RL, Loss of the hyaluronan receptor RHAMM prevents constrictive artery wall remodeling. J Vasc Surg 2014 59 804 813. doi: 10.1016/j.jvs.2013.03.047.
6. Bot PT, Hoefer IE, Piek JJ, Pasterkamp G, Hyaluronic acid: targeting immune modulatory components of the extracellular matrix in atherosclerosis. Curr Med Chem 2008 15 786 791
7. Bot PT, Pasterkamp G, Goumans MJ, Strijder C, Moll FL, de Vries JP, Pals ST, de Kleijn DP, Piek JJ, Hoefer IE, Hyaluronic acid metabolism is increased in unstable plaques. Eur J Clin Invest 2010 40 818 827. doi: 10.1111/j.1365-2362.2010.02326.x.
8. Wight TN, Merrilees MJ, Proteoglycans in atherosclerosis and restenosis: key roles for versican. Circ Res 2004 94 1158 1167. doi: 10.1161/01.RES.0000126921.29919.51.
9. Sussmann M, Sarbia M, Meyer-Kirchrath J, Nüsing RM, Schrör K, Fischer JW, Induction of hyaluronic acid synthase 2 (HAS2) in human vascular smooth muscle cells by vasodilatory prostaglandins. Circ Res 2004 94 592 600. doi: 10.1161/01.RES.0000119169.87429.A0.
10. van den Boom M, Sarbia M, von Wnuck Lipinski K, Mann P, Meyer-Kirchrath J, Rauch BH, Grabitz K, Levkau B, Schrör K, Fischer JW, Differential regulation of hyaluronic acid synthase isoforms in human saphenous vein smooth muscle cells: possible implications for vein graft stenosis. Circ Res 2006 98 36 44. doi: 10.1161/01.RES.0000199263.67107.c0.
11. Grandoch M, Hoffmann J, Röck K, Wenzel F, Oberhuber A, Schelzig H, Fischer JW, Novel effects of adenosine receptors on pericellular hyaluronan matrix: implications for human smooth muscle cell phenotype and interactions with monocytes during atherosclerosis. Basic Res Cardiol 2013 108 340. doi: 10.1007/s00395-013-0340-6.
12. Wilkinson TS, Bressler SL, Evanko SP, Braun KR, Wight TN, Overexpression of hyaluronan synthases alters vascular smooth muscle cell phenotype and promotes monocyte adhesion. J Cell Physiol 2006 206 378 385. doi: 10.1002/jcp.20468.
13. Camenisch TD, Spicer AP, Brehm-Gibson T, Biesterfeldt J, Augustine ML, Calabro A Jr, Kubalak S, Klewer SE, McDonald JA, Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J Clin Invest 2000 106 349 360. doi: 10.1172/JCI10272.
14. Yokoyama U, Minamisawa S, Quan H, Ghatak S, Akaike T, Segi-Nishida E, Iwasaki S, Iwamoto M, Misra S, Tamura K, Hori H, Yokota S, Toole BP, Sugimoto Y, Ishikawa Y, Chronic activation of the prostaglandin receptor EP4 promotes hyaluronan-mediated neointimal formation in the ductus arteriosus. J Clin Invest 2006 116 3026 3034. doi: 10.1172/JCI28639.
15. Kashima Y, Takahashi M, Shiba Y, Itano N, Izawa A, Koyama J, Nakayama J, Taniguchi S, Kimata K, Ikeda U, Crucial role of hyaluronan in neointimal formation after vascular injury. PLoS One 2013 8 e58760. doi: 10.1371/journal.pone.0058760.
16. Chai S, Chai Q, Danielsen CC, Hjorth P, Nyengaard JR, Ledet T, Yamaguchi Y, Rasmussen LM, Wogensen L, Overexpression of hyaluronan in the tunica media promotes the development of atherosclerosis. Circ Res 2005 96 583 591. doi: 10.1161/01.RES.0000158963.37132.8b.
17. Vigetti D, Viola M, Karousou E, Rizzi M, Moretto P, Genasetti A, Clerici M, Hascall VC, De Luca G, Passi A, Hyaluronan-CD44-ERK1/2 regulate human aortic smooth muscle cell motility during aging. J Biol Chem 2008 283 4448 4458. doi: 10.1074/jbc.M709051200.
18. Viola M, Bartolini B, Vigetti D, Karousou E, Moretto P, Deleonibus S, Sawamura T, Wight TN, Hascall VC, De Luca G, Passi A, Oxidized low density lipoprotein (LDL) affects hyaluronan synthesis in human aortic smooth muscle cells. J Biol Chem 2013 288 29595 29603. doi: 10.1074/jbc.M113.508341.
19. Kumar A, Hoover JL, Simmons CA, Lindner V, Shebuski RJ, Remodeling and neointimal formation in the carotid artery of normal and P-selectin-deficient mice. Circulation 1997 96 4333 4342
20. Ferns GA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R, Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 1991 253 1129 1132
21. Jawien A, Bowen-Pope DF, Lindner V, Schwartz SM, Clowes AW, Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest 1992 89 507 511. doi: 10.1172/JCI115613.
22. Kumar A, Lindner V, Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler Thromb Vasc Biol 1997 17 2238 2244
23. El Kasmi KC, Qualls JE, Pesce JT, Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat Immunol 2008 9 1399 1406. doi: 10.1038/ni.1671.
24. Lavin B, Gómez M, Pello OM, Castejon B, Piedras MJ, Saura M, Zaragoza C, Nitric oxide prevents aortic neointimal hyperplasia by controlling macrophage polarization. Arterioscler Thromb Vasc Biol 2014 34 1739 1746. doi: 10.1161/ATVBAHA.114.303866.
25. Farb A, Kolodgie FD, Hwang JY, Burke AP, Tefera K, Weber DK, Wight TN, Virmani R, Extracellular matrix changes in stented human coronary arteries. Circulation 2004 110 940 947. doi: 10.1161/01.CIR.0000139337.56084.30.
26. Savani RC, Wang C, Yang B, Zhang S, Kinsella MG, Wight TN, Stern R, Nance DM, Turley EA, Migration of bovine aortic smooth muscle cells after wounding injury. The role of hyaluronan and RHAMM. J Clin Invest 1995 95 1158 1168. doi: 10.1172/JCI117764.
27. Jain M, He Q, Lee WS, Kashiki S, Foster LC, Tsai JC, Lee ME, Haber E, Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury. J Clin Invest 1996 97 596 603. doi: 10.1172/JCI118455.
28. Zhao L, Lee E, Zukas AM, Middleton MK, Kinder M, Acharya PS, Hall JA, Rader DJ, Puré E, CD44 expressed on both bone marrow-derived and non-bone marrow-derived cells promotes atherogenesis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2008 28 1283 1289. doi: 10.1161/ATVBAHA.108.165753.
29. Cuff CA, Kothapalli D, Azonobi I, Chun S, Zhang Y, Belkin R, Yeh C, Secreto A, Assoian RK, Rader DJ, Puré E, The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation. J Clin Invest 2001 108 1031 1040. doi: 10.1172/JCI12455.
30. Foster LC, Wiesel P, Huggins GS, Pañares R, Chin MT, Pellacani A, Perrella MA, Role of activating protein-1 and high mobility group-I(Y) protein in the induction of CD44 gene expression by interleukin-1beta in vascular smooth muscle cells. FASEB J 2000 14 368 378
31. Foster LC, Arkonac BM, Sibinga NE, Shi C, Perrella MA, Haber E, Regulation of CD44 gene expression by the proinflammatory cytokine interleukin-1beta in vascular smooth muscle cells. J Biol Chem 1998 273 20341 20346
32. Shishido T, Nozaki N, Takahashi H, Arimoto T, Niizeki T, Koyama Y, Abe J, Takeishi Y, Kubota I, Central role of endogenous Toll-like receptor-2 activation in regulating inflammation, reactive oxygen species production, and subsequent neointimal formation after vascular injury. Biochem Biophys Res Commun 2006 345 1446 1453. doi: 10.1016/j.bbrc.2006.05.056.
33. Karper JC, de Vries MR, van den Brand BT, Hoefer IE, Fischer JW, Jukema JW, Niessen HW, Quax PH, Toll-like receptor 4 is involved in human and mouse vein graft remodeling, and local gene silencing reduces vein graft disease in hypercholesterolemic APOE∗3Leiden mice. Arterioscler Thromb Vasc Biol 2011 31 1033 1040. doi: 10.1161/ATVBAHA.111.223271.